Literature DB >> 10326078

Bootstrapping: estimating confidence intervals for cost-effectiveness ratios.

M K Campbell1, D J Torgerson.   

Abstract

Economic evaluations are increasingly being conducted alongside clinical trials of health interventions, with resource consequences being estimated from stochastic data. It is, therefore, important that economic evaluation results, like the clinical results, reflect the underlying variance within the sample data. A statistical methodology, known as bootstrapping, has recently been put forward as a potential method for calculating confidence intervals for cost-effectiveness ratios, yet it is still unusual to see economic evaluations reporting confidence intervals. In this paper we demonstrate the practical application of bootstrapping using real data from clinical trials, and conclude that bootstrapping is easily transferable from theory to practice for the estimation of confidence intervals for cost-effectiveness ratios. We encourage further investigation into its applicability and use.

Mesh:

Year:  1999        PMID: 10326078     DOI: 10.1093/qjmed/92.3.177

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  47 in total

1.  The Cost of Increasing Physical Activity and Maintaining Weight for Midlife Sedentary African American Women.

Authors:  Tricia J Johnson; Michael E Schoeny; Louis Fogg; JoEllen Wilbur
Journal:  Value Health       Date:  2015-12-02       Impact factor: 5.725

2.  The case for stratified cost-effectiveness analysis by baseline health-related QOL: theory and sensitivity analysis.

Authors:  Joseph Schaafsma
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.

Authors:  Christopher Rao; Omer Aziz; Sukhmeet Singh Panesar; Catherine Jones; Stephen Morris; Ara Darzi; Thanos Athanasiou
Journal:  BMJ       Date:  2007-03-02

4.  Longitudinal direct medical costs associated with constipation in women.

Authors:  R S Choung; M E Branda; D Chitkara; N D Shah; S K Katusic; G R Locke; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-11-22       Impact factor: 8.171

5.  Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin.

Authors:  Isabelle Gaboury; Kathryn Coyle; Douglas Coyle; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2010-09       Impact factor: 2.253

6.  Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity.

Authors:  Vasileios Fragoulakis; Rossana Roncato; Chiara Dalle Fratte; Fabrizio Ecca; Marina Bartsakoulia; Federico Innocenti; Giuseppe Toffoli; Erika Cecchin; George P Patrinos; Christina Mitropoulou
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

7.  Cost-utility analysis of aprepitant for patients who truly need it in Japan.

Authors:  Ikuto Tsukiyama; Masahiko Ando; Sumiyo Tsukiyama; Masayuki Takeuchi; Masayuki Ejiri; Yusuke Kurose; Hiroko Saito; Ichiro Arakawa; Tadao Inoue; Etsuro Yamaguchi; Akihito Kubo
Journal:  Support Care Cancer       Date:  2019-02-01       Impact factor: 3.603

8.  Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies.

Authors:  Carlos Crespo; Antonio Monleon; Walter Díaz; Martín Ríos
Journal:  BMC Med Res Methodol       Date:  2014-12-22       Impact factor: 4.615

9.  The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting.

Authors:  R B Morgan; L McCullagh; M Barry; C Daly
Journal:  Ir J Med Sci       Date:  2016-11-19       Impact factor: 1.568

10.  Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.

Authors:  María Del Carmen Vennera; Antonio Valero; Estefany Uría; Carles Forné; César Picado
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.